Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Portfolio · 31 May 2026
From the fund’s own N-PORT filingThe fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 40 positions. The ten largest identified positions carry 54.7% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Travere Therapeutics Inc TVTX | Healthcare | United States | 7.66% | $8.05M |
| 2 | Cogent Biosciences Inc COGT | Healthcare | United States | 7.52% | $7.90M |
| 3 | LivaNova PLC LIVN | Healthcare | United Kingdom | 7.10% | $7.46M |
| 4 | Spyre Therapeutics Inc SYRE | Healthcare | United States | 6.40% | $6.73M |
| 5 | Guardant Health Inc GH | Healthcare | United States | 5.51% | $5.79M |
| 6 | Mirum Pharmaceuticals Inc MIRM | Healthcare | United States | 4.91% | $5.16M |
Source: SEC filings. Information and analytics, not investment advice.